Insufficient scRNA-seq data for expression of HTR1F at single-cell level.
Insufficient scRNA-seq data for expression of HTR1F at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 67.96 | 457 / 459 | 13% | 0.39 | 147 / 1118 |
thymus | 99% | 40.62 | 644 / 653 | 12% | 0.30 | 71 / 605 |
lung | 97% | 39.08 | 563 / 578 | 6% | 0.14 | 67 / 1155 |
uterus | 98% | 45.89 | 167 / 170 | 5% | 0.23 | 22 / 459 |
adipose | 99% | 92.57 | 1195 / 1204 | 0% | 0 | 0 / 0 |
ovary | 80% | 19.14 | 144 / 180 | 13% | 0.37 | 54 / 430 |
spleen | 92% | 29.38 | 221 / 241 | 0% | 0 | 0 / 0 |
prostate | 86% | 20.47 | 211 / 245 | 2% | 0.04 | 11 / 502 |
muscle | 86% | 17.41 | 693 / 803 | 0% | 0 | 0 / 0 |
skin | 77% | 23.57 | 1396 / 1809 | 4% | 0.24 | 20 / 472 |
brain | 77% | 17.45 | 2026 / 2642 | 4% | 0.05 | 25 / 705 |
pancreas | 67% | 11.84 | 221 / 328 | 6% | 0.13 | 10 / 178 |
bladder | 62% | 12.05 | 13 / 21 | 9% | 0.34 | 46 / 504 |
heart | 66% | 12.30 | 570 / 861 | 0% | 0 | 0 / 0 |
kidney | 26% | 9.64 | 23 / 89 | 38% | 1.13 | 339 / 901 |
esophagus | 59% | 9.16 | 855 / 1445 | 0% | 0 | 0 / 183 |
intestine | 47% | 7.35 | 456 / 966 | 2% | 0.03 | 8 / 527 |
blood vessel | 47% | 10.14 | 632 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 19% | 3.03 | 49 / 258 | 7% | 0.13 | 17 / 230 |
stomach | 17% | 2.46 | 61 / 359 | 1% | 0.02 | 4 / 286 |
peripheral blood | 13% | 2.02 | 121 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
liver | 0% | 0.04 | 1 / 226 | 1% | 0.06 | 4 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007198 | Biological process | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0030425 | Cellular component | dendrite |
GO_0045202 | Cellular component | synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0051378 | Molecular function | serotonin binding |
GO_0004993 | Molecular function | G protein-coupled serotonin receptor activity |
GO_0030594 | Molecular function | neurotransmitter receptor activity |
Gene name | HTR1F |
Protein name | 5-hydroxytryptamine receptor 1F (5-HT-1F) (5-HT1F) (Serotonin receptor 1F) 5-hydroxytryptamine receptor 1F (Serotonin receptor 1F) |
Synonyms | HTR1EL |
Description | FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various alkaloids and psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. . FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various alkaloids and psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. . |
Accessions | P30939 ENST00000319595.7 Q9P2Q4 |